Siemens Healthcare Diagnostics, Inc.: Medical Device Recall in 2024 - (Recall #: Z-1281-2024)

Updated on March 25, 2026.

See the recall detail below. You can also see other recalls from the same firm in 2024.

Data Source: FDA.

Product Description:

ADVIA Centaur Erythropoietin (EPO) Assay (100 Test)

Product Classification:

Class II

Date Initiated: January 24, 2024

Date Posted: March 20, 2024

Recall Number: Z-1281-2024

Event ID: 93939

Reason for Recall:

Siemens Healthcare Diagnostics has confirmed an average negative bias of -35% compared to the 3rd World Health Organization (WHO) International Standard (NIBSC code: 11/170) that is proportional across the assay measuring interval. The reference interval as claimed in the Instructions for Use (IFU) is not achieved with affected lots.

Status: Ongoing

Product Quantity: 264 units (6 US, 258 OUS)

Code Information:

Siemens Material Number: 10995096; UDI/DI: 00630414010380; Kit Lots: 53984040, 55443042.

Distribution Pattern:

Worldwide - US Nationwide distribution in the states of AL, CA, IA, IL, MI, MN, NC, NE, NV, NY, OH and TX; The countries of Australia, Austria, Bahrain, Bangladesh, Belgium, Brazil, Colombia, Croatia, Czech Republic, Denmark, Ecuador, Egypt, France, Germany, Greece, India, Italy, Japan, Latvia, Malaysia, Netherlands, Norway, P.R. China, Pakistan, Poland, Portugal, Republic of South Korea, Romania, Saudi Arabia, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, U.A.E., United Kingdom.

Voluntary or Mandated:

Voluntary: Firm initiated